Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma neurofilament heavy chain levels in Huntington's disease.

Neuroscience letters - 7 May 2007

Wild Edward J, Petzold Axel, Keir Geoff, Tabrizi Sarah J

Abstract excerpt

There is a need for biomarkers of onset and progression in Huntington's disease (HD), as current outcome measures lack the reliability to enable the efficient conduct of disease-modifying trials. Neurofilament heavy chain (NfH) is a neuron-specific protein for the neuro-axonal compartment that has been proposed as a marker for axonal injury, degeneration and loss and its clinical use as a biomarker has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Axons
Share to Brain Chemistry
Share to Early Diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Huntingtin Protein

Share to Huntington Disease

Share to Nerve Degeneration

Share to Neurofilament Proteins

Share to Trinucleotide Repeat Expansion

Source

Identifiers

PMID: 17363167
DOI: 10.1016/j.neulet.2007.02.053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma neurofilament heavy chain levels in Huntington's disease.PMID 17363167Read ↗

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.Semantic proximity Read ↗

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisSemantic proximity Read ↗

Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?Semantic proximity Read ↗

Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional studySemantic proximity Read ↗

Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF studySemantic proximity Read ↗

Neurofilament light protein as a blood biomarker for Huntington’s disease in childrenSemantic proximity Read ↗

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s diseaseSemantic proximity Read ↗

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in ChildrenSemantic proximity Read ↗

Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s diseaseSemantic proximity Read ↗

Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s diseaseSemantic proximity Read ↗

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker.Semantic proximity Read ↗

Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.